Review



rabbit polyclonal anti pcdh1 primary antibody  (Bioss)


Bioz Verified Symbol Bioss is a verified supplier
Bioz Manufacturer Symbol Bioss manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    Bioss rabbit polyclonal anti pcdh1 primary antibody
    Expression of 3 hub genes (A) Gene expression of KCNK1, <t>PCDH1</t> and SDR16C5. (B) Expression of KCNK1 in a single cell. (C) Expression of PCDH1 in a single cell. (D) Expression of SDR16C5 in a single cell.
    Rabbit Polyclonal Anti Pcdh1 Primary Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+polyclonal+anti+pcdh1+primary+antibody/PCDH1+Polyclonal+Antibody/pmc12832269-105-9-15
    Average 94 stars, based on 1 article reviews
    rabbit polyclonal anti pcdh1 primary antibody - by Bioz Stars, 2026-09
    94/100 stars

    Images

    1) Product Images from "PCDH1 facilitates migration, proliferation, and stemness of pancreatic cancer cells through PI3K-Akt signaling"

    Article Title: PCDH1 facilitates migration, proliferation, and stemness of pancreatic cancer cells through PI3K-Akt signaling

    Journal: Frontiers in Oncology

    doi: 10.3389/fonc.2025.1696695

    Expression of 3 hub genes (A) Gene expression of KCNK1, PCDH1 and SDR16C5. (B) Expression of KCNK1 in a single cell. (C) Expression of PCDH1 in a single cell. (D) Expression of SDR16C5 in a single cell.
    Figure Legend Snippet: Expression of 3 hub genes (A) Gene expression of KCNK1, PCDH1 and SDR16C5. (B) Expression of KCNK1 in a single cell. (C) Expression of PCDH1 in a single cell. (D) Expression of SDR16C5 in a single cell.

    Techniques Used: Expressing, Gene Expression

    Related assays on the expression of hub genes. (A–C) mRNA expression of KCNK1, PCDH1 and SDR16C5 in HPNE and BXPC3. (D) mRNA expression of PCDH1 in HPNE and multiple PDAC cell lines. (E) Matched pairs of PDAC tissues and adjacent non-neoplastic pancreatic tissues were stained with PCDH1-specific antibodies for immunohistochemical analysis. Representative images of tissues and tumor-infiltrating cells are shown (100×, scale bar = 100 μm; 400×, scale bar = 20 μm). The MOD of PCDH1 is obtained by analyzing the photo-optical density with IPP software. (F) ROC curve of PCDH1 in PDAC. (G) Protein-protein interaction network of PCDH1. (ns: P >0.05, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001).
    Figure Legend Snippet: Related assays on the expression of hub genes. (A–C) mRNA expression of KCNK1, PCDH1 and SDR16C5 in HPNE and BXPC3. (D) mRNA expression of PCDH1 in HPNE and multiple PDAC cell lines. (E) Matched pairs of PDAC tissues and adjacent non-neoplastic pancreatic tissues were stained with PCDH1-specific antibodies for immunohistochemical analysis. Representative images of tissues and tumor-infiltrating cells are shown (100×, scale bar = 100 μm; 400×, scale bar = 20 μm). The MOD of PCDH1 is obtained by analyzing the photo-optical density with IPP software. (F) ROC curve of PCDH1 in PDAC. (G) Protein-protein interaction network of PCDH1. (ns: P >0.05, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001).

    Techniques Used: Expressing, Staining, Immunohistochemical staining, Software

    Correlation between PCDH1 and immune infiltration. (A) Correlation between PCDH1 and immune score. (B) Correlation between PCDH1 and stromal score. (C) Correlation between PCDH1 and ESTIMATE score. (D) Correlation between PCDH1 and immune cells. (* P < 0.05, ** P < 0.01).
    Figure Legend Snippet: Correlation between PCDH1 and immune infiltration. (A) Correlation between PCDH1 and immune score. (B) Correlation between PCDH1 and stromal score. (C) Correlation between PCDH1 and ESTIMATE score. (D) Correlation between PCDH1 and immune cells. (* P < 0.05, ** P < 0.01).

    Techniques Used:

    Chemosensitivity of PCDH1. (A) Correlation between GDSC drug sensitivity and PCDH1 mRNA expression (B) Correlation between CTRP drug sensitivity and PCDH1 mRNA expression.
    Figure Legend Snippet: Chemosensitivity of PCDH1. (A) Correlation between GDSC drug sensitivity and PCDH1 mRNA expression (B) Correlation between CTRP drug sensitivity and PCDH1 mRNA expression.

    Techniques Used: Expressing

    Knockdown of PCDH1 inhibited the proliferation of PDAC. (A) Efficiency of knocking down mRNA of PCDH1 si-RNA in BXPC3. (B) Efficiency of knocking down mRNA of PCDH1 si-RNA in SW1990. (C, E) MTT assays reveal the proliferation ability of control group and PCDH1 knockdown group in cell line BXPC3 and SW1990. (D, F) Colony formation assays reveal the proliferation ability of control group and PCDH1 knockdown group in cell line BXPC3 and SW1990. (ns: P >0.05, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001).
    Figure Legend Snippet: Knockdown of PCDH1 inhibited the proliferation of PDAC. (A) Efficiency of knocking down mRNA of PCDH1 si-RNA in BXPC3. (B) Efficiency of knocking down mRNA of PCDH1 si-RNA in SW1990. (C, E) MTT assays reveal the proliferation ability of control group and PCDH1 knockdown group in cell line BXPC3 and SW1990. (D, F) Colony formation assays reveal the proliferation ability of control group and PCDH1 knockdown group in cell line BXPC3 and SW1990. (ns: P >0.05, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001).

    Techniques Used: Knockdown, Control

    Knockdown of PCDH1 inhibited the migration of PDAC. (A) Transwell assays show the migration ability of the control group and the PCDH1 knockdown group in the BXPC3 cell line. (Scale bar = 50μm) (B) Transwell assays show the migration ability of the control group and the PCDH1 knockdown group in the SW1990 cell line. (Scale bar = 50μm) (C) Wound healing assays exhibit the migration ability of the control group and the PCDH1 knockdown group in the BXPC3 cell line. (Scale bar = 100μm) (D) Wound healing assays exhibit the migration ability of the control group and the PCDH1 knockdown group in the SW1990 cell line. (Scale bar = 100μm) (ns: P >0.05, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001).
    Figure Legend Snippet: Knockdown of PCDH1 inhibited the migration of PDAC. (A) Transwell assays show the migration ability of the control group and the PCDH1 knockdown group in the BXPC3 cell line. (Scale bar = 50μm) (B) Transwell assays show the migration ability of the control group and the PCDH1 knockdown group in the SW1990 cell line. (Scale bar = 50μm) (C) Wound healing assays exhibit the migration ability of the control group and the PCDH1 knockdown group in the BXPC3 cell line. (Scale bar = 100μm) (D) Wound healing assays exhibit the migration ability of the control group and the PCDH1 knockdown group in the SW1990 cell line. (Scale bar = 100μm) (ns: P >0.05, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001).

    Techniques Used: Knockdown, Migration, Control

    Knockdown of PCDH1 inhibited the tumor stemness of PDAC cell lines. (A) Relative expression of CD24 mRNA in the control group and the PCDH1 knockdown group. (B) Relative expression of CD133 mRNA in the control group and the PCDH1 knockdown group. (C) Detection of CD24 + cells in the control and PCDH1 knockdown groups via flow cytometry in BXPC3 and SW1990 cell lines. (D) Detection of CD133 + cells in the control and PCDH1 knockdown groups via flow cytometry in BXPC3 and SW1990 cell lines. (E, F) Percentage of CD24 + cells between the control group and the PCDH1 knockdown group (G, H) Percentage of CD133 + cells between the control group and the PCDH1 knockdown group. (I, J) Sphere formation assay was performed to detect sphere formation ability of the control group and the PCDH1 knockdown group in BXPC3 and SW1990. (K, L) Diameter of tumor spheres at 24 h, 48 h and 5 days in the control group and the PCDH1 knockdown group.(Scale bar = 500μm) (ns: P >0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001).
    Figure Legend Snippet: Knockdown of PCDH1 inhibited the tumor stemness of PDAC cell lines. (A) Relative expression of CD24 mRNA in the control group and the PCDH1 knockdown group. (B) Relative expression of CD133 mRNA in the control group and the PCDH1 knockdown group. (C) Detection of CD24 + cells in the control and PCDH1 knockdown groups via flow cytometry in BXPC3 and SW1990 cell lines. (D) Detection of CD133 + cells in the control and PCDH1 knockdown groups via flow cytometry in BXPC3 and SW1990 cell lines. (E, F) Percentage of CD24 + cells between the control group and the PCDH1 knockdown group (G, H) Percentage of CD133 + cells between the control group and the PCDH1 knockdown group. (I, J) Sphere formation assay was performed to detect sphere formation ability of the control group and the PCDH1 knockdown group in BXPC3 and SW1990. (K, L) Diameter of tumor spheres at 24 h, 48 h and 5 days in the control group and the PCDH1 knockdown group.(Scale bar = 500μm) (ns: P >0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001).

    Techniques Used: Knockdown, Expressing, Control, Flow Cytometry, Tube Formation Assay

    PCDH1 promotes proliferation and migration of PDAC through activation of PI3K/Akt pathway. (A) Heatmap of differential expression genes between the NC and si-PCDH1 groups. (B) KEGG enrichment analysis demonstrates pathways associated with differential expression genes. (C, D) Expression levels of mRNA for six molecules in the PI3K/Akt pathway were detected by qRT-PCR. (*** P < 0.001, **** P < 0.0001).
    Figure Legend Snippet: PCDH1 promotes proliferation and migration of PDAC through activation of PI3K/Akt pathway. (A) Heatmap of differential expression genes between the NC and si-PCDH1 groups. (B) KEGG enrichment analysis demonstrates pathways associated with differential expression genes. (C, D) Expression levels of mRNA for six molecules in the PI3K/Akt pathway were detected by qRT-PCR. (*** P < 0.001, **** P < 0.0001).

    Techniques Used: Migration, Activation Assay, Quantitative Proteomics, Expressing, Quantitative RT-PCR

    PCDH1 promotes proliferation and migration of PDAC through activation of PI3K/Akt pathway. (A, B) MTT assay was used to detect the proliferation ability of the control, IGF-1, si-PCDH1, and si-PCDH1 + IGF-1 groups. (C–E) A colony formation assay was performed to detect the proliferation ability of the four groups. (* P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001).
    Figure Legend Snippet: PCDH1 promotes proliferation and migration of PDAC through activation of PI3K/Akt pathway. (A, B) MTT assay was used to detect the proliferation ability of the control, IGF-1, si-PCDH1, and si-PCDH1 + IGF-1 groups. (C–E) A colony formation assay was performed to detect the proliferation ability of the four groups. (* P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001).

    Techniques Used: Migration, Activation Assay, MTT Assay, Control, Colony Assay

    PCDH1 promotes proliferation and migration of PDAC through activation of PI3K/Akt pathway. (A) Transwell assays present the migration capacity of the control, IGF-1, si-PCDH1, and si-PCDH1 + IGF-1 groups. (Scale bar = 100μm) (B, C) Counts of cell migration in four groups. (D, F) Wound healing assays exhibit the migration ability of the four groups. (Scale bar = 100μm) (E, G) Rate of cell migration in four groups. (** P < 0.01, *** P < 0.001, **** P < 0.00011).
    Figure Legend Snippet: PCDH1 promotes proliferation and migration of PDAC through activation of PI3K/Akt pathway. (A) Transwell assays present the migration capacity of the control, IGF-1, si-PCDH1, and si-PCDH1 + IGF-1 groups. (Scale bar = 100μm) (B, C) Counts of cell migration in four groups. (D, F) Wound healing assays exhibit the migration ability of the four groups. (Scale bar = 100μm) (E, G) Rate of cell migration in four groups. (** P < 0.01, *** P < 0.001, **** P < 0.00011).

    Techniques Used: Migration, Activation Assay, Control

    Related Articles

    Incubation:

    Article Title: PCDH1 facilitates migration, proliferation, and stemness of pancreatic cancer cells through PI3K-Akt signaling
    Article Snippet: .. Slides were incubated overnight at 4 °C with a rabbit polyclonal anti-PCDH1 primary antibody (bs-111111R, Bioss Biotechnology, China) at the manufacturer-recommended dilution. .. After PBS rinsing, sections were incubated with a horseradish peroxidase (HRP)-conjugated secondary IgG antibody (PV-9000, ZSGB-BIO, China) for 20 min at room temperature.



    Similar Products

    rabbit polyclonal anti pcdh1 primary antibody  (Bioss)
    94
    Bioss rabbit polyclonal anti pcdh1 primary antibody
    Expression of 3 hub genes (A) Gene expression of KCNK1, <t>PCDH1</t> and SDR16C5. (B) Expression of KCNK1 in a single cell. (C) Expression of PCDH1 in a single cell. (D) Expression of SDR16C5 in a single cell.
    Rabbit Polyclonal Anti Pcdh1 Primary Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/rabbit+polyclonal+anti+pcdh1+primary+antibody/PCDH1+Polyclonal+Antibody/pmc12832269-105-9-15
    Average 94 stars, based on 1 article reviews
    rabbit polyclonal anti pcdh1 primary antibody - by Bioz Stars, 2026-09
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    Expression of 3 hub genes (A) Gene expression of KCNK1, PCDH1 and SDR16C5. (B) Expression of KCNK1 in a single cell. (C) Expression of PCDH1 in a single cell. (D) Expression of SDR16C5 in a single cell.

    Journal: Frontiers in Oncology

    Article Title: PCDH1 facilitates migration, proliferation, and stemness of pancreatic cancer cells through PI3K-Akt signaling

    doi: 10.3389/fonc.2025.1696695

    Figure Lengend Snippet: Expression of 3 hub genes (A) Gene expression of KCNK1, PCDH1 and SDR16C5. (B) Expression of KCNK1 in a single cell. (C) Expression of PCDH1 in a single cell. (D) Expression of SDR16C5 in a single cell.

    Article Snippet: Slides were incubated overnight at 4 °C with a rabbit polyclonal anti-PCDH1 primary antibody (bs-111111R, Bioss Biotechnology, China) at the manufacturer-recommended dilution.

    Techniques: Expressing, Gene Expression

    Related assays on the expression of hub genes. (A–C) mRNA expression of KCNK1, PCDH1 and SDR16C5 in HPNE and BXPC3. (D) mRNA expression of PCDH1 in HPNE and multiple PDAC cell lines. (E) Matched pairs of PDAC tissues and adjacent non-neoplastic pancreatic tissues were stained with PCDH1-specific antibodies for immunohistochemical analysis. Representative images of tissues and tumor-infiltrating cells are shown (100×, scale bar = 100 μm; 400×, scale bar = 20 μm). The MOD of PCDH1 is obtained by analyzing the photo-optical density with IPP software. (F) ROC curve of PCDH1 in PDAC. (G) Protein-protein interaction network of PCDH1. (ns: P >0.05, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001).

    Journal: Frontiers in Oncology

    Article Title: PCDH1 facilitates migration, proliferation, and stemness of pancreatic cancer cells through PI3K-Akt signaling

    doi: 10.3389/fonc.2025.1696695

    Figure Lengend Snippet: Related assays on the expression of hub genes. (A–C) mRNA expression of KCNK1, PCDH1 and SDR16C5 in HPNE and BXPC3. (D) mRNA expression of PCDH1 in HPNE and multiple PDAC cell lines. (E) Matched pairs of PDAC tissues and adjacent non-neoplastic pancreatic tissues were stained with PCDH1-specific antibodies for immunohistochemical analysis. Representative images of tissues and tumor-infiltrating cells are shown (100×, scale bar = 100 μm; 400×, scale bar = 20 μm). The MOD of PCDH1 is obtained by analyzing the photo-optical density with IPP software. (F) ROC curve of PCDH1 in PDAC. (G) Protein-protein interaction network of PCDH1. (ns: P >0.05, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001).

    Article Snippet: Slides were incubated overnight at 4 °C with a rabbit polyclonal anti-PCDH1 primary antibody (bs-111111R, Bioss Biotechnology, China) at the manufacturer-recommended dilution.

    Techniques: Expressing, Staining, Immunohistochemical staining, Software

    Correlation between PCDH1 and immune infiltration. (A) Correlation between PCDH1 and immune score. (B) Correlation between PCDH1 and stromal score. (C) Correlation between PCDH1 and ESTIMATE score. (D) Correlation between PCDH1 and immune cells. (* P < 0.05, ** P < 0.01).

    Journal: Frontiers in Oncology

    Article Title: PCDH1 facilitates migration, proliferation, and stemness of pancreatic cancer cells through PI3K-Akt signaling

    doi: 10.3389/fonc.2025.1696695

    Figure Lengend Snippet: Correlation between PCDH1 and immune infiltration. (A) Correlation between PCDH1 and immune score. (B) Correlation between PCDH1 and stromal score. (C) Correlation between PCDH1 and ESTIMATE score. (D) Correlation between PCDH1 and immune cells. (* P < 0.05, ** P < 0.01).

    Article Snippet: Slides were incubated overnight at 4 °C with a rabbit polyclonal anti-PCDH1 primary antibody (bs-111111R, Bioss Biotechnology, China) at the manufacturer-recommended dilution.

    Techniques:

    Chemosensitivity of PCDH1. (A) Correlation between GDSC drug sensitivity and PCDH1 mRNA expression (B) Correlation between CTRP drug sensitivity and PCDH1 mRNA expression.

    Journal: Frontiers in Oncology

    Article Title: PCDH1 facilitates migration, proliferation, and stemness of pancreatic cancer cells through PI3K-Akt signaling

    doi: 10.3389/fonc.2025.1696695

    Figure Lengend Snippet: Chemosensitivity of PCDH1. (A) Correlation between GDSC drug sensitivity and PCDH1 mRNA expression (B) Correlation between CTRP drug sensitivity and PCDH1 mRNA expression.

    Article Snippet: Slides were incubated overnight at 4 °C with a rabbit polyclonal anti-PCDH1 primary antibody (bs-111111R, Bioss Biotechnology, China) at the manufacturer-recommended dilution.

    Techniques: Expressing

    Knockdown of PCDH1 inhibited the proliferation of PDAC. (A) Efficiency of knocking down mRNA of PCDH1 si-RNA in BXPC3. (B) Efficiency of knocking down mRNA of PCDH1 si-RNA in SW1990. (C, E) MTT assays reveal the proliferation ability of control group and PCDH1 knockdown group in cell line BXPC3 and SW1990. (D, F) Colony formation assays reveal the proliferation ability of control group and PCDH1 knockdown group in cell line BXPC3 and SW1990. (ns: P >0.05, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001).

    Journal: Frontiers in Oncology

    Article Title: PCDH1 facilitates migration, proliferation, and stemness of pancreatic cancer cells through PI3K-Akt signaling

    doi: 10.3389/fonc.2025.1696695

    Figure Lengend Snippet: Knockdown of PCDH1 inhibited the proliferation of PDAC. (A) Efficiency of knocking down mRNA of PCDH1 si-RNA in BXPC3. (B) Efficiency of knocking down mRNA of PCDH1 si-RNA in SW1990. (C, E) MTT assays reveal the proliferation ability of control group and PCDH1 knockdown group in cell line BXPC3 and SW1990. (D, F) Colony formation assays reveal the proliferation ability of control group and PCDH1 knockdown group in cell line BXPC3 and SW1990. (ns: P >0.05, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001).

    Article Snippet: Slides were incubated overnight at 4 °C with a rabbit polyclonal anti-PCDH1 primary antibody (bs-111111R, Bioss Biotechnology, China) at the manufacturer-recommended dilution.

    Techniques: Knockdown, Control

    Knockdown of PCDH1 inhibited the migration of PDAC. (A) Transwell assays show the migration ability of the control group and the PCDH1 knockdown group in the BXPC3 cell line. (Scale bar = 50μm) (B) Transwell assays show the migration ability of the control group and the PCDH1 knockdown group in the SW1990 cell line. (Scale bar = 50μm) (C) Wound healing assays exhibit the migration ability of the control group and the PCDH1 knockdown group in the BXPC3 cell line. (Scale bar = 100μm) (D) Wound healing assays exhibit the migration ability of the control group and the PCDH1 knockdown group in the SW1990 cell line. (Scale bar = 100μm) (ns: P >0.05, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001).

    Journal: Frontiers in Oncology

    Article Title: PCDH1 facilitates migration, proliferation, and stemness of pancreatic cancer cells through PI3K-Akt signaling

    doi: 10.3389/fonc.2025.1696695

    Figure Lengend Snippet: Knockdown of PCDH1 inhibited the migration of PDAC. (A) Transwell assays show the migration ability of the control group and the PCDH1 knockdown group in the BXPC3 cell line. (Scale bar = 50μm) (B) Transwell assays show the migration ability of the control group and the PCDH1 knockdown group in the SW1990 cell line. (Scale bar = 50μm) (C) Wound healing assays exhibit the migration ability of the control group and the PCDH1 knockdown group in the BXPC3 cell line. (Scale bar = 100μm) (D) Wound healing assays exhibit the migration ability of the control group and the PCDH1 knockdown group in the SW1990 cell line. (Scale bar = 100μm) (ns: P >0.05, * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001).

    Article Snippet: Slides were incubated overnight at 4 °C with a rabbit polyclonal anti-PCDH1 primary antibody (bs-111111R, Bioss Biotechnology, China) at the manufacturer-recommended dilution.

    Techniques: Knockdown, Migration, Control

    Knockdown of PCDH1 inhibited the tumor stemness of PDAC cell lines. (A) Relative expression of CD24 mRNA in the control group and the PCDH1 knockdown group. (B) Relative expression of CD133 mRNA in the control group and the PCDH1 knockdown group. (C) Detection of CD24 + cells in the control and PCDH1 knockdown groups via flow cytometry in BXPC3 and SW1990 cell lines. (D) Detection of CD133 + cells in the control and PCDH1 knockdown groups via flow cytometry in BXPC3 and SW1990 cell lines. (E, F) Percentage of CD24 + cells between the control group and the PCDH1 knockdown group (G, H) Percentage of CD133 + cells between the control group and the PCDH1 knockdown group. (I, J) Sphere formation assay was performed to detect sphere formation ability of the control group and the PCDH1 knockdown group in BXPC3 and SW1990. (K, L) Diameter of tumor spheres at 24 h, 48 h and 5 days in the control group and the PCDH1 knockdown group.(Scale bar = 500μm) (ns: P >0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001).

    Journal: Frontiers in Oncology

    Article Title: PCDH1 facilitates migration, proliferation, and stemness of pancreatic cancer cells through PI3K-Akt signaling

    doi: 10.3389/fonc.2025.1696695

    Figure Lengend Snippet: Knockdown of PCDH1 inhibited the tumor stemness of PDAC cell lines. (A) Relative expression of CD24 mRNA in the control group and the PCDH1 knockdown group. (B) Relative expression of CD133 mRNA in the control group and the PCDH1 knockdown group. (C) Detection of CD24 + cells in the control and PCDH1 knockdown groups via flow cytometry in BXPC3 and SW1990 cell lines. (D) Detection of CD133 + cells in the control and PCDH1 knockdown groups via flow cytometry in BXPC3 and SW1990 cell lines. (E, F) Percentage of CD24 + cells between the control group and the PCDH1 knockdown group (G, H) Percentage of CD133 + cells between the control group and the PCDH1 knockdown group. (I, J) Sphere formation assay was performed to detect sphere formation ability of the control group and the PCDH1 knockdown group in BXPC3 and SW1990. (K, L) Diameter of tumor spheres at 24 h, 48 h and 5 days in the control group and the PCDH1 knockdown group.(Scale bar = 500μm) (ns: P >0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001).

    Article Snippet: Slides were incubated overnight at 4 °C with a rabbit polyclonal anti-PCDH1 primary antibody (bs-111111R, Bioss Biotechnology, China) at the manufacturer-recommended dilution.

    Techniques: Knockdown, Expressing, Control, Flow Cytometry, Tube Formation Assay

    PCDH1 promotes proliferation and migration of PDAC through activation of PI3K/Akt pathway. (A) Heatmap of differential expression genes between the NC and si-PCDH1 groups. (B) KEGG enrichment analysis demonstrates pathways associated with differential expression genes. (C, D) Expression levels of mRNA for six molecules in the PI3K/Akt pathway were detected by qRT-PCR. (*** P < 0.001, **** P < 0.0001).

    Journal: Frontiers in Oncology

    Article Title: PCDH1 facilitates migration, proliferation, and stemness of pancreatic cancer cells through PI3K-Akt signaling

    doi: 10.3389/fonc.2025.1696695

    Figure Lengend Snippet: PCDH1 promotes proliferation and migration of PDAC through activation of PI3K/Akt pathway. (A) Heatmap of differential expression genes between the NC and si-PCDH1 groups. (B) KEGG enrichment analysis demonstrates pathways associated with differential expression genes. (C, D) Expression levels of mRNA for six molecules in the PI3K/Akt pathway were detected by qRT-PCR. (*** P < 0.001, **** P < 0.0001).

    Article Snippet: Slides were incubated overnight at 4 °C with a rabbit polyclonal anti-PCDH1 primary antibody (bs-111111R, Bioss Biotechnology, China) at the manufacturer-recommended dilution.

    Techniques: Migration, Activation Assay, Quantitative Proteomics, Expressing, Quantitative RT-PCR

    PCDH1 promotes proliferation and migration of PDAC through activation of PI3K/Akt pathway. (A, B) MTT assay was used to detect the proliferation ability of the control, IGF-1, si-PCDH1, and si-PCDH1 + IGF-1 groups. (C–E) A colony formation assay was performed to detect the proliferation ability of the four groups. (* P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001).

    Journal: Frontiers in Oncology

    Article Title: PCDH1 facilitates migration, proliferation, and stemness of pancreatic cancer cells through PI3K-Akt signaling

    doi: 10.3389/fonc.2025.1696695

    Figure Lengend Snippet: PCDH1 promotes proliferation and migration of PDAC through activation of PI3K/Akt pathway. (A, B) MTT assay was used to detect the proliferation ability of the control, IGF-1, si-PCDH1, and si-PCDH1 + IGF-1 groups. (C–E) A colony formation assay was performed to detect the proliferation ability of the four groups. (* P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001).

    Article Snippet: Slides were incubated overnight at 4 °C with a rabbit polyclonal anti-PCDH1 primary antibody (bs-111111R, Bioss Biotechnology, China) at the manufacturer-recommended dilution.

    Techniques: Migration, Activation Assay, MTT Assay, Control, Colony Assay

    PCDH1 promotes proliferation and migration of PDAC through activation of PI3K/Akt pathway. (A) Transwell assays present the migration capacity of the control, IGF-1, si-PCDH1, and si-PCDH1 + IGF-1 groups. (Scale bar = 100μm) (B, C) Counts of cell migration in four groups. (D, F) Wound healing assays exhibit the migration ability of the four groups. (Scale bar = 100μm) (E, G) Rate of cell migration in four groups. (** P < 0.01, *** P < 0.001, **** P < 0.00011).

    Journal: Frontiers in Oncology

    Article Title: PCDH1 facilitates migration, proliferation, and stemness of pancreatic cancer cells through PI3K-Akt signaling

    doi: 10.3389/fonc.2025.1696695

    Figure Lengend Snippet: PCDH1 promotes proliferation and migration of PDAC through activation of PI3K/Akt pathway. (A) Transwell assays present the migration capacity of the control, IGF-1, si-PCDH1, and si-PCDH1 + IGF-1 groups. (Scale bar = 100μm) (B, C) Counts of cell migration in four groups. (D, F) Wound healing assays exhibit the migration ability of the four groups. (Scale bar = 100μm) (E, G) Rate of cell migration in four groups. (** P < 0.01, *** P < 0.001, **** P < 0.00011).

    Article Snippet: Slides were incubated overnight at 4 °C with a rabbit polyclonal anti-PCDH1 primary antibody (bs-111111R, Bioss Biotechnology, China) at the manufacturer-recommended dilution.

    Techniques: Migration, Activation Assay, Control